Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04113499 · ClinicalTrials.gov registry record · NA
Endoscopic Necrosectomy Versus Step-up Endoscopic Intervention
A NA study of Pancreatic Necrosis and Necrosis Pancreas, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT04113499: Completed NA study of Pancreatic Necrosis and Necrosis Pancreas, sponsored by AdventHealth.
NCT04113499 is a NA study of Pancreatic Necrosis and Necrosis Pancreas that has completed, run by AdventHealth. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04113499, a NA study of Pancreatic Necrosis and Necrosis Pancreas, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial is to compare clinical outcomes between patients undergoing immediate endoscopic necrosectomy compared to step-up endoscopic interventions in patients undergoing endoscopic therapy for infected necrotizing pancreatitis.
Primary Outcome
Treatment success is defined as the resolution of necrotic collection on CT scan in association with clinical resolution of symptoms at 6-month follow-up
Conditions Studied
Interventions
- PROCEDURE Direct Endoscopic Intervention
- PROCEDURE Step-up Endoscopic Intervention
Study Locations (1)
Florida
- Center for Interventional Endoscopy - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-11-27 |
| Est. Completion | 2022-04-25 |
| Phase | NA |
What the finished NCT04113499 record still lists
NCT04113499 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Pancreatic Necrosis appearing as the primary indexed condition, and to 2 interventions - of which Direct Endoscopic Intervention is the first listed.
NCT04113499 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04113499 about?
NCT04113499 is a clinical study titled "Endoscopic Necrosectomy Versus Step-up Endoscopic Intervention". This trial is to compare clinical outcomes between patients undergoing immediate endoscopic necrosectomy compared to step-up endoscopic interventions in patients undergoing endoscopic therapy for infected necrotizing pancreatitis.
What is the current status of trial NCT04113499?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2019-11-27. Estimated completion is 2022-04-25.
What conditions does trial NCT04113499 study?
This clinical trial studies the following conditions: Pancreatic Necrosis, Necrosis Pancreas.
What interventions are being tested in trial NCT04113499?
The interventions under investigation include: Direct Endoscopic Intervention (PROCEDURE), Step-up Endoscopic Intervention (PROCEDURE).
Who is sponsoring clinical trial NCT04113499?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04113499 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Necrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04113499's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI